Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00109538
Status:
TERMINATED
Last Update Posted:
2015-05-01
First Post:
2005-04-28
Brief Title:
Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome MDS or Chronic Myelomonocytic Leukemia CMML Study P02978AM3TERMINATED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelomonocytic |
| Myelodysplastic Syndromes |
| Leukemia Myelomonocytic Chronic |
| Myelodysplasia |
Keywords:
| Name | View |
|---|---|
| Lonafarnib | View |